Accelerating the evolution of immune-related enterocolitis management Editorial
| Authors: | Faleck, D. M.; Dougan, M.; Tello, M.; Grossman, J. E.; Moss, A. C.; Postow, M. A. |
| Title: | Accelerating the evolution of immune-related enterocolitis management |
| Keywords: | fracture; drug efficacy; drug safety; side effect; systemic therapy; note; outcome assessment; treatment indication; infection; heart disease; steroid; practice guideline; drug fatality; body mass; corticosteroid; immunosuppressive treatment; sleep disorder; immunopathology; mood disorder; immunosuppressive agent; venous thromboembolism; enterocolitis; hip fracture; randomized controlled trial (topic); meta analysis (topic); comparative effectiveness; tumor necrosis factor inhibitor; gastrointestinal infection; corticosteroid therapy; inflammatory bowel disease; tofacitinib; humans; human; fecal microbiota transplantation; malignant neoplasm; vedolizumab; ustekinumab; risankizumab; immune related enterocolitis |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 41 |
| Issue: | 17 |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2023-06-10 |
| Start Page: | 3110 |
| End Page: | 3115 |
| Language: | English |
| DOI: | 10.1200/jco.22.02914 |
| PUBMED: | 37040601 |
| PROVIDER: | scopus |
| PMCID: | PMC10256374 |
| DOI/URL: | |
| Notes: | The MSK Cancer Center Support Grant (P30 CA008748) is acknowledged in the PDF. Corresponding author is MSK author David M Faleck -- Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
